Retinal projections were examined in two small dasyurids, the kowari and the fat-tailed dunnart, following injections of 3H-proline into one eye. In both animals retinal fibres terminate in the dorsal and ventral lateral geniculate nuclei (LGd, LGv), the lateral posterior nuclear complex, the pretectum, the superior colliculus, the suprachiasmatic nucleus of the hypothalamus and the nuclei of the accessory optic system. The lateroposterior thalamic complex and the accessory optic nuclei receive projections from the contralateral eye only; the remaining centres receive bilateral inputs. Both LGd contain an undifferentiated Β or medial segment and an Α or lateral segment that comprises further cellular sublaminae, 4 in the kowari and 3 in the dunnart. There is substantial overlap of crossed and uncrossed terminals in both segments, though in each animal a narrow cell lamina next to the optic tract receives only crossed projections and the lateral part of the Β segment receives only uncrossed projections. There is a cell-sparse zone within the Α segment that receives a predominately uncrossed projection in the kowari and a crossed projection in the dunnart. In both marsupials the density of crossed and uncrossed terminals is equal, a feature of dasyurid quolls but not of another dasyurid, the Tasmanian devil. Additionally, retinal terminals do not form dense clusters within the LGd neuropil. This feature is characteristic of quolls, but not of other mammals, marsupial or placental, all of which display LGd terminal clusters. These findings suggest that the functional organisation of the LGd in these dasyurids may differ from that found in other marsupials.

Keywords:
Accessory optic system, Autoradiography, CNS, Cytoarchitecture, Comparative neuroanatomy, Dark-field microscopy, Dorsal lateral geniculate nucleus, Retinal terminals, Visual system, Thalamus, visual
This content is only available via PDF.
© 1988 S. Karger AG, Basel
1988
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.